These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17544376)

  • 1. The reactivity of ortho-methoxy-substituted catechol radicals with sulfhydryl groups: contribution for the comprehension of the mechanism of inhibition of NADPH oxidase by apocynin.
    Kanegae MP; da Fonseca LM; Brunetti IL; Silva SO; Ximenes VF
    Biochem Pharmacol; 2007 Aug; 74(3):457-64. PubMed ID: 17544376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oxidation of apocynin catalyzed by myeloperoxidase: proposal for NADPH oxidase inhibition.
    Ximenes VF; Kanegae MP; Rissato SR; Galhiane MS
    Arch Biochem Biophys; 2007 Jan; 457(2):134-41. PubMed ID: 17166480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols.
    Johnson DK; Schillinger KJ; Kwait DM; Hughes CV; McNamara EJ; Ishmael F; O'Donnell RW; Chang MM; Hogg MG; Dordick JS; Santhanam L; Ziegler LM; Holland JA
    Endothelium; 2002; 9(3):191-203. PubMed ID: 12380644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol.
    Stolk J; Hiltermann TJ; Dijkman JH; Verhoeven AJ
    Am J Respir Cell Mol Biol; 1994 Jul; 11(1):95-102. PubMed ID: 8018341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-oxidant activity of apocynin radical.
    Castor LR; Locatelli KA; Ximenes VF
    Free Radic Biol Med; 2010 Jun; 48(12):1636-43. PubMed ID: 20304045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition.
    Schlüter T; Steinbach AC; Steffen A; Rettig R; Grisk O
    Cardiovasc Res; 2008 Nov; 80(2):271-9. PubMed ID: 18596059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress.
    Riganti C; Costamagna C; Bosia A; Ghigo D
    Toxicol Appl Pharmacol; 2006 May; 212(3):179-87. PubMed ID: 16120450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adventitial application of the NADPH oxidase inhibitor apocynin in vivo reduces neointima formation and endothelial dysfunction in rabbits.
    Chan EC; Datla SR; Dilley R; Hickey H; Drummond GR; Dusting GJ
    Cardiovasc Res; 2007 Sep; 75(4):710-8. PubMed ID: 17659266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NADPH oxidase inhibitor, apocynin, improves renal glutathione status in Zucker diabetic fatty rats: a comparison with melatonin.
    Winiarska K; Focht D; Sierakowski B; Lewandowski K; Orlowska M; Usarek M
    Chem Biol Interact; 2014 Jul; 218():12-9. PubMed ID: 24797087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Antioxidant and Anti-inflammatory Properties of an Apocynin- Derived Dihydrocoumarin.
    Paracatu LC; Zeraik ML; Bertozo LC; Bartolomeu AA; Filho LCDS; Fonseca LMD; Ximenes VF
    Med Chem; 2016; 13(1):93-100. PubMed ID: 27292257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diapocynin versus apocynin as pretranscriptional inhibitors of NADPH oxidase and cytokine production by peripheral blood mononuclear cells.
    Kanegae MP; Condino-Neto A; Pedroza LA; de Almeida AC; Rehder J; da Fonseca LM; Ximenes VF
    Biochem Biophys Res Commun; 2010 Mar; 393(3):551-4. PubMed ID: 20171179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of co-administration of dietary sodium arsenite and an NADPH oxidase inhibitor on the rat bladder epithelium.
    Suzuki S; Arnold LL; Pennington KL; Kakiuchi-Kiyota S; Cohen SM
    Toxicology; 2009 Jun; 261(1-2):41-6. PubMed ID: 19397947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis.
    de Almeida AC; Cabral Marques O; Arslanian C; Condino-Neto A; Ximenes VF
    Eur J Pharmacol; 2011 Jun; 660(2-3):445-53. PubMed ID: 21497599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
    Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
    Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of NADPH oxidase by apocynin inhibits lipopolysaccharide (LPS) induced up-regulation of arginase in rat alveolar macrophages.
    Matthiesen S; Lindemann D; Warnken M; Juergens UR; Racké K
    Eur J Pharmacol; 2008 Jan; 579(1-3):403-10. PubMed ID: 18001708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells.
    Vejrazka M; Mícek R; Stípek S
    Biochim Biophys Acta; 2005 Mar; 1722(2):143-7. PubMed ID: 15716123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apocynin alleviated hepatic oxidative burden and reduced liver injury in hypercholesterolaemia.
    Lu LS; Wu CC; Hung LM; Chiang MT; Lin CT; Lin CW; Su MJ
    Liver Int; 2007 May; 27(4):529-37. PubMed ID: 17403193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
    Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
    Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
    Nam SM; Lee MY; Koh JH; Park JH; Shin JY; Shin YG; Koh SB; Lee EY; Chung CH
    Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase.
    Tawfik A; Sanders T; Kahook K; Akeel S; Elmarakby A; Al-Shabrawey M
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):878-84. PubMed ID: 18806296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.